Where does Genesis Technologies Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Genesis Technologies Limited ranks #14,638 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Genesis Technologies Limited hold?

Genesis Technologies Limited holds 20 US utility patents granted between 2015 and 2024, spanning 13 technology areas.

What is Genesis Technologies Limited's Innovation Score?

Genesis Technologies Limited has an Innovation Score of 35.6 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Genesis Technologies Limited's patent grant rate increasing or decreasing?

Genesis Technologies Limited's recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Genesis Technologies Limited's patents?

Genesis Technologies Limited's patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Genesis Technologies Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Genesis Technologies Limited

Q: What technology areas does Genesis Technologies Limited focus on?

Genesis Technologies Limited's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 10 patents, ranking #1,018 of 4,144 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 20 granted patents across 13 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genesis ranks #14,638 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 13 technology areas.

#14,638
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.6/100): 16.9
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14638 · Foreign Corporation #14,638 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,638/49,997
PHOTO-FINISH Ganeden Biotech
CPC-FOCUS C12N · 13 areas
INNOV-THIN 35.6/100
CLAIMS-RICH 16.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ganeden Biotech, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Genesis’s 35.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (30%) Velocity 2.2 pts (6%) Breadth 12.7 pts (36%) Claim depth 10.1 pts (28%)

Qualcomm Incorporated · highest

85
Genesis · this assignee

36
3D Lighting… · lowest

7

What this shows Genesis's Innovation Score is 35.6/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Genesis?

Each dot is one of Genesis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Genesis’s own 16.9 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Genesis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Genesis's grants concentrate

Genesis Technologies Limited is a focused PatentsView assignee: 13 CPC subclasses with 50% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2015. By volume, Genesis sits between Green Idea Tech Inc. and Giesecke+Devrient Mobile Security America, Inc..

Genesis's three-year grant acceleration

Genesis Technologies Limited shows 3 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Green Idea Tech

20
Guangdong Welling…

20
Guangzhou Alpha C…

20
Ganeden Biotech

20
Genomic Health

20
Genpact Luxembour…

20
Geobrugg

20
Giesecke+Devrient…

20
Genesis ◀

20

What this shows Genesis holds 20 patents at rank #14,645, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Genesis

By rank, the assignees closest to #14,645 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Genesis's primary technology class.

Genesis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Genesis Technologies Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.0%
2016	3	15.0%
2018	4	20.0%
2019	4	20.0%
2020	2	10.0%
2021	3	15.0%
2023	2	10.0%
2024	1	5.0%

Which technologies does Genesis Technologies Limited patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 10

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

C07K - Peptides 3

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

A61B - DIAGNOSIS; SURGERY; Identification 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07D - Heterocyclic Compounds 1

C07C - Acyclic OR Carbocyclic Compounds 1

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Genesis Technologies Limited's patent record in context - here's where to go next.

Genesis Technologies Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 50% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #14,638 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Genesis Technologies Limited against Green Idea Tech Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.